Neko Health raises $700 million to launch consumer body-scanning platform

Neko Health announced a $700 million financing round aimed at building a consumer-focused body-scanning service. The funding, led by investors that include Preface Ventures, positions the company to develop hardware and software that can map a person’s internal health in minutes. The capital raise underscores a growing belief among venture capitalists that preventative health, powered by advanced imaging, could become a mainstream part of everyday wellness.

Founded by Spotify co-founder Daniel Ek, Neko Health plans to commercialize a scanner that captures detailed internal images without invasive procedures. The company’s ambition is to translate those images into actionable health insights for users, potentially shifting the focus from treatment to early detection. While the exact pricing and rollout timeline were not disclosed, the size of the round suggests the startup will invest heavily in research, regulatory pathways, and consumer education.

Neko Health is not alone in betting on body-scanning technology. Midjourney, known for its generative-AI tools, is reportedly developing its own scanner, while Function Health has raised a sizable, though undisclosed, amount to expand a preventative-health platform that also relies on internal imaging. The convergence of AI, imaging hardware, and consumer health apps has attracted capital across the sector, reflecting a broader trend toward data-driven wellness solutions.

In a recent episode of TechCrunch’s Equity podcast, Dominic-Madori Davis spoke with Farooq Abbasi, founder and general partner of Preface Ventures and an investor in Neko Health. Abbasi compared Neko’s approach with other consumer-health startups, noting that success will hinge on integrating scanning results into existing medical workflows and gaining acceptance from clinicians. He emphasized that regulatory clearance, insurance reimbursement, and robust clinical validation are essential milestones before the technology can move beyond early adopters.

The discussion also highlighted the challenge of scaling a hardware-intensive product in a market dominated by established imaging providers. Abbasi suggested that partnerships with hospitals, health insurers, and electronic-medical-record platforms could accelerate adoption. For founders, the conversation reinforced the importance of aligning product development with clear pathways to reimbursement and demonstrating measurable health outcomes.

As Neko Health prepares to bring its scanner to market, investors will watch closely to see whether the company can translate its substantial funding into a viable consumer product. The next steps will involve clinical trials, regulatory submissions, and building a distribution network capable of reaching a broad user base. If successful, Neko could set a precedent for how advanced imaging integrates into daily health management, potentially reshaping the preventive-care landscape.